Evidence map›Paper›PMID 39039451›Full record

SynthesisBMC ophthalmology2024

Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review.

Mohammad Taher Rajabi, Reza Sadeghi, Mohammad Reza Abdol Homayuni, Saharnaz Pezeshgi, Seyedeh Simindokht Hosseini, Mohammad Bagher Rajabi, Sepideh Poshtdar

Abstract readSystematic Review
In one paragraph

Synthesis in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Optical coherence tomography angiography measurements in patients with HIV: a systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad Taher Rajabi *Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Zip Code: 1336616351, Tehran, Iran.
Reza Sadeghi *Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Zip Code: 1336616351, Tehran, Iran.
Mohammad Reza Abdol HomayuniEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Zip Code: 1336616351, Tehran, Iran.
Saharnaz PezeshgiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Zip Code: 1336616351, Tehran, Iran.
Seyedeh Simindokht HosseiniEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Zip Code: 1336616351, Tehran, Iran.
Mohammad Bagher RajabiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Zip Code: 1336616351, Tehran, Iran.
Sepideh PoshtdarEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Zip Code: 1336616351, Tehran, Iran. Sepideh.pdr@gmail.com.ORCID http://orcid.org/0009-0007-3552-4137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the evidence for alterations of blood flow, vascular and perfusion densities in the choroid, macula, peripapillary region, and the area surrounding the optic nerve head (ONH) in patients with thyroid-associated ophthalmopathy (TAO) based on changes of OCTA parameters.

methodsA systematic review of Pubmed, Google Scholar, Scopus, WOS, Cochrane, and Embase databases, including quality assessment of published studies, investigating the alterations of OCTA parameters in TAO patients was conducted. The outcomes of interest comprised changes of perfusion and vascular densities in radial peripapillary capillary (RPC), ONH, superficial and deep retinal layers (SRL and DRL), choriocapillaris (CC) flow, and the extent of the foveal avascular zone (FAZ).

resultsFrom the total of 1253 articles obtained from the databases, the pool of papers was narrowed down to studies published until March 20th, 2024. Lastly, 42 studies were taken into consideration which contained the data regarding the alterations of OCTA parameters including choriocapillary vascular flow, vascular and perfusion densities of retinal microvasculature, SRL, and DRL, changes in macular all grid sessions, changes of foveal, perifoveal and parafoveal densities, macular whole image vessel density (m-wiVD) and FAZ, in addition to alterations of ONH and RPC whole image vessel densities (onh-wiVD and rpc-wiVD) among TAO patients. The correlation of these parameters with visual field-associated parameters, such as Best-corrected visual acuity (BCVA), Visual field mean defect (VF-MD), axial length (AL), P100 amplitude, and latency, was also evaluated among TAO patients.

conclusionThe application of OCTA has proven helpful in distinguishing active and inactive TAO patients, as well as differentiation of patients with or without DON, indicating the potential promising role of some OCTA measures for early detection of TAO with high sensitivity and specificity in addition to preventing the irreversible outcomes of TAO. OCTA assessments have also been applied to evaluate the effectiveness of TAO treatment approaches, including systemic corticosteroid therapy and surgical decompression.

Indexed as

Fluorescein AngiographyGraves OphthalmopathyRetinal VesselsTomography, Optical CoherenceChoroidFundus OculiHumansMacula LuteaOptic DiskRegional Blood FlowVisual AcuityGraves' orbitopathyOptical coherence tomography angiographyThyroid-associated ophthalmopathy

Identifiers

PMID39039451
PMCPMC11265183

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.